Welcome to our dedicated page for Marimed news (Ticker: MRMD), a resource for investors and traders seeking the latest updates and insights on Marimed stock.
MariMed Inc. (MRMD) generates frequent news as a multi-state cannabis operator and cannabis consumer packaged goods company focused on branded products, facility operations, and regulatory developments. Its releases cover both corporate performance and brand-level activity across cultivation, production, and retail channels.
On this page, readers can follow MariMed’s earnings announcements, where the company discusses revenue trends, gross margins, net income or loss, and non-GAAP measures such as Adjusted EBITDA. These updates often include commentary on wholesale and retail performance, as well as progress on what management calls its "Expand the Brand" strategy to grow top-selling cannabis brands.
MariMed’s news flow also highlights product and brand developments. Examples include new limited-edition Betty’s Eddies™ fruit chews, extensions to the Nature’s Heritage™ product line, and initiatives for Vibations™ and InHouse™. The company reports on licensing and managed services agreements that bring its brands into additional states, as well as strategic decisions such as exiting specific markets after operational reviews.
In addition, MariMed issues releases on community and veteran-focused initiatives tied to its Thrive dispensaries and brands, along with commentary on major policy changes affecting cannabis, such as the rescheduling of cannabis at the federal level. Investors and observers can use this news feed to monitor how MariMed communicates its strategy, brand expansion, financial performance, and responses to regulatory and market changes over time.
MariMed (OTCQX:MRMD) has launched the second annual Help on the Homefront campaign through its InHouse cannabis brand, offering veterans a chance to win financial support for housing costs. From October 1 to November 30, 2025, qualifying veterans in Maryland, Massachusetts, Delaware, and Illinois can enter to win $5,000 to help with housing expenses or home improvements.
The campaign, accessible through MariMed's Thrive dispensaries or online at inhousecannabis.com/veterans, will select one winner from each market before year-end. No purchase is necessary, and friends and family can submit entries on veterans' behalf. The initiative aims to address veteran housing challenges and homelessness while demonstrating MariMed's commitment to community support.
MariMed (OTCQX: MRMD), a prominent cannabis consumer packaged goods company and retailer, has scheduled its third quarter 2025 financial results announcement for November 5, 2025, after market close.
The company will host a conference call to discuss the results on November 6, 2025, at 8:00 a.m. EDT. Investors can access the webcast through MariMed's Investor Relations website, where a playback will also be available following the call.
MariMed's (OTCQX: MRMD) Betty's Eddies brand announced its third annual collaboration with the Keep A Breast Foundation (KAB) for Breast Cancer Awareness Month. The partnership features a limited-edition pink package of Ache Away Eddies cannabis fruit chews, available in Massachusetts, Maryland, Illinois, and Delaware.
The campaign promotes the free Keep A Breast app for self-checking education and medical professional connections. Betty's Eddies will distribute limited-edition merchandise and donate $5 from each t-shirt sale to KAB. Additionally, team members will participate in Susan G. Komen More Than Pink Walks in Maryland (October 11) and Massachusetts (October 18).
MariMed Inc. (OTCQX: MRMD) reported its Q2 2025 financial results, showing mixed performance. Revenue reached $39.6 million, slightly down from $40.4 million in Q2 2024. The company posted a GAAP net loss of $1.3 million but achieved non-GAAP Adjusted EBITDA of $4.9 million, up from $4.4 million year-over-year.
Key operational highlights include launching Nature's Heritage™ products in Illinois, introducing new Betty's Eddies™ caramel chews, and expanding to Maine through a licensing partnership. The company also announced a significant Managed Services Agreement in Pennsylvania with TILT Holdings, positioning for potential adult-use market expansion.
Despite challenges, MariMed maintained strong gross margins of 40% GAAP and 42% non-GAAP, while implementing its 'Expand the Brand' strategy across core markets.
MariMed (OTCQX: MRMD) has entered into a strategic Management Services Agreement (MSA) with TILT Holdings' subsidiary Standard Farms to expand into Pennsylvania's medical marijuana market. Starting September 1, 2025, MariMed will manage TILT's cultivation and processing facility in White Haven, Pennsylvania.
Under the 4-year agreement, MariMed will receive a 12.5% management fee of Standard Farms' gross revenue. The company will oversee daily operations, including budgeting, financial planning, compliance, and quality management. Additionally, Standard Farms will produce and distribute MariMed's branded products in Pennsylvania through a licensing arrangement.
MariMed (OTCQX: MRMD) has announced a new licensing agreement with The Stoned Moose to expand distribution of its Betty's Eddies™ full-spectrum fruit chews in Maine's $455 million cannabis market. The partnership will extend the brand's reach to include both adult-use and medical cannabis consumers, with medical sales representing over half of Maine's cannabis revenues in 2024.
Previously available only to adult-use consumers since 2022, Betty's Eddies will now be accessible to medical cannabis patients through The Stoned Moose's dual-license capabilities. The brand currently holds market leadership in edibles across Massachusetts, Maryland, and Delaware, targeting Maine's local consumer base and its 15 million annual tourists.
MariMed (OTCQX: MRMD) has announced a new licensing agreement with The Stoned Moose to expand distribution of its Betty's Eddies™ full-spectrum fruit chews in Maine's $455 million cannabis market. The partnership will extend the brand's reach to include both adult-use and medical cannabis consumers.
Previously available only to adult-use consumers since 2022, Betty's Eddies will now be accessible to medical cannabis patients, a significant market segment that represented over half of Maine's cannabis revenues in 2024. The brand currently leads market share for edibles in Massachusetts, Maryland, and Delaware.
MariMed Inc. (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, has scheduled its second quarter 2025 earnings release for August 6, 2025, after market close.
The company will host a conference call to discuss the financial results on August 7, 2025, at 8:00 a.m. EDT. Investors can access the webcast through MariMed's Investor Relations website, where a playback will also be available following the call.
MariMed (MRMD) has announced its readiness to participate in Delaware's expansion into adult-use cannabis sales, which will commence on August 1st, 2025. Through its Delaware business unit, First State Compassion (FSC), which has been the state's first licensed operator for 10 years, MariMed has already implemented improvements at its dispensaries in Wilmington and Lewes to handle increased customer traffic.
The company has begun scaling production at its cultivation and processing facilities in Wilmington and Milford to meet anticipated demand from both residents and the nearly 30 million annual tourists. MariMed's product portfolio in Delaware includes Betty's Eddies chews, currently the state's top-selling edible, along with FSC and Nature's Heritage flower brands, both ranking in the top five.
[ "First-mover advantage as Delaware's first licensed cannabis operator", "Strategic positioning with two dispensary locations in Wilmington and Lewes", "Market leadership with top-selling products including #1 edible brand", "Access to potential market of 30 million annual tourists", "Facilities already upgraded to handle increased customer traffic" ]